FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I):
,
wherein in general formula (I) n1 is selected from 0 or 1; Z is 
, where the carbon atom marked with * represents a center of asymmetry; each of R1, R3, R4, R5, R6, R7, R8 and R9 is independently selected from H or D; R2 is selected from H, D or F; each of L1 and L2 is independently selected from CD2, CHD or CH2; X is selected from NH, ND or O; R10 is H, D or 
, where each of R2', R3', R4' and R5' is independently selected from H, D, halogen, cyano, hydroxy, 
, 
, 
, 
, substituted or unsubstituted (C1-C12)alkyl, substituted or unsubstituted (C1-C12)alkoxy, (C2-C20)heterocycloalkyl or deuterated (C2-C20)heterocycloalkyl; where each of Ra and Rb independently is H, (C1-C12)alkyl, (C1-C12)alkylacyl; each of Rc and Rd independently represents H or (C1-C12)alkyl; Re is 
or (C2-C20)heterocycloalkyl; wherein each of Re1 and Re2 independently represents H or (C1-C12)alkyl.
EFFECT: compounds are able to regulate activity of immunological cytokines, thus effectively curing cancer and inflammatory disease.
14 cl, 3 tbl, 78 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OESTROGEN RECEPTOR MODULATING COMPOUNDS | 2019 |
|
RU2826635C2 |
| INHIBITORS OF CDK | 2011 |
|
RU2621674C2 |
| DERIVATIVE BASED ON DIHYDROPYRIMIDO-RING AS HBV INHIBITOR | 2015 |
|
RU2693897C2 |
| ISOINDOLINE DERIVATIVE, ITS PHARMACEUTICAL COMPOSITION AND USE | 2021 |
|
RU2809680C1 |
| NEW 3-INDOLE SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION | 2016 |
|
RU2672252C1 |
| COMPOSITIONS FOR TREATING RENAL AND/OR HEPATIC DISORDERS | 2016 |
|
RU2712624C2 |
| ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
| AZABICYCLIC AND DIAZEPINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISORDERS | 2018 |
|
RU2795521C2 |
| BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES USEFUL FOR TREATING NEOPLASTIC AND/OR INFECTIOUS DISEASES | 2016 |
|
RU2730524C2 |
| 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | 2020 |
|
RU2820477C1 |
